Is Autonomix Medical, Inc. (AMIX) a Buy, Sell, or Hold?
NASDAQ : AMIX
Autonomix Medical, Inc.
$9.0901 USD
-$0.2 (-2.15%)
- Volume
- 93.77K
- Average Volume
- 1.57M
- Market Capitalization
- $4.94M
- P/E Ratio
- -0.14
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $32.55
- Year Low
- $2.44
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $4.45
Company Overview
NASDAQ
Bradley A. Hauser
Medical - Devices
Healthcare
AMIX
10
US
USD
Liquidity Metrics
0.00
4.45
4.45
4.11
0.00
Sales & Valuation
-$
0.00
0.84
-0.44
-20.51
Profitability
-$48.72
-$16.72M
0.00%
0.00%
-239.36%
-219.93%
P/E Metrics
-0.14
0.00
0.00
Analyst Price Target & Rating
2/5
1 Analysts
%
Financial Health Scores
-16.95
1/9
$5.88M
$7.6M
$1.7M
-$16.79M
Key Metrics (TTM)
-$1.96M
0.00
0.12
4.45
-239.36%
-288.97%
-331.17%
-220.90%
-85167 days
Company Executives
| Name | Title |
|---|---|
| Trent N. Smith | Chief Financial Officer |
| David A. Robins | Co-Founder & Independent Director |
| Jennifer Cook | Chief Business Officer |
| Bradley Hauser | Chief Executive Officer & President |
| Robert Schwartz | Co-Founder & Chief Medical Officer |
| Landy Toth | Co-Founder & Chief Technology Officer |
| Walter V. Klemp | Executive Chairman |
| Lori H. Bisson | Executive Vice Chairman |
Poll Results
No votes yet today — be the first to share your view!
About Autonomix Medical, Inc. (NASDAQ:AMIX) Stock
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas. ...
2026-08-10 08:20:00
Recognition honors one of the medical technology industry's most influential innovators, whose career has helped shape modern cardiovascular care
Autonomix Stock Skyrockets After Obtaining Key Cancer Tech Patent
2026-08-04 15:27:25
Autonomix Medical Inc. (NASDAQ:AMIX) shares are skyrocketing Tuesday afternoon after securing U.S. Patent No. 12,433,670.
2026-08-04 08:15:00
Patent expands protection for technology designed to sense, map and selectively target nerves associated with tumors and cancer-related pain
Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study
2026-07-24 08:47:00
Data demonstrate the ability to detect, localize and confirm changes in renal neural activity, supporting continued development of physiology-guided renal denervation THE WOODLANDS, TX, July 24, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced positive results from a preclinical study demonstrating the ability of its proprietary neural sensing platform to detect, localize and confirm changes in renal neural activity.
Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study
2026-07-24 08:47:00
Data demonstrate the ability to detect, localize and confirm changes in renal neural activity, supporting continued development of physiology-guided renal denervation
2026-07-23 07:30:00
Patent Broadens Intellectual Property Protecting Advanced Autonomic Nervous System Assessment Technologies Designed to Enhance Patient Selection, Treatment Precision and Future Clinical Applications THE WOODLANDS, TX, July 23, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the issuance of U.S. Patent No. 12,471,776, titled "ANS Assessment Systems, Kits, and Methods," further strengthening the Company's intellectual property portfolio supporting its proprietary autonomic nervous system technologies.
Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform
2026-07-15 08:00:00
Newly Issued Patent Expands Company's Neural Sensing Technology Platform into Large Urology Market Affecting Approximately 37 Million Americans THE WOODLANDS, TX, July 15, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, announced today that the United States Patent and Trademark Office has issued U.S. Patent No. 12,611,134, titled “Devices, Systems, and Methods for Diagnosis and Treatment of Overactive Bladder.
2026-07-13 21:30:00
THE WOODLANDS, TX, July 13, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) ("Autonomix" or the "Company"), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it has entered into a warrant inducement agreement with an investor ("Investor") for the immediate exercise of certain outstanding warrants that the Company issued on November 19, 2025 (the "November 2025 Warrants").
Frequently Asked Questions
-
What is the current Autonomix Medical, Inc. (AMIX) stock price?
-
Autonomix Medical, Inc.(NASDAQ:AMIX) stock price is $9.0901 in the last trading session. During the trading session, AMIX stock reached the peak price of $32.55 while $2.44 was the lowest point it dropped to. The percentage change in AMIX stock occurred in the recent session was --2.15% while the dollar amount for the price change in AMIX stock was -$0.2.
-
AMIX's industry and sector of operation?
-
The NASDAQ listed AMIX is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of AMIX?
-
Trent N. Smith | Chief Financial Officer
David A. Robins | Co-Founder & Independent Director
Jennifer Cook | Chief Business Officer
Bradley Hauser | Chief Executive Officer & President
Robert Schwartz | Co-Founder & Chief Medical Officer -
How many employees does AMIX have?
-
Number of AMIX employees currently stands at 10. AMIX operates from 21 Waterway Avenue, The Woodlands, TX 77380, US.
-
Link for AMIX official website?
-
Official Website of AMIX is: https://autonomix.com
-
How do I contact AMIX?
-
AMIX could be contacted at phone #713 588 6150 and can also be accessed through its website. AMIX operates from 21 Waterway Avenue, The Woodlands, TX 77380, US.
-
How many shares of AMIX are traded daily?
-
The average number of AMIX shares traded daily for last 3 months was 1.57M.
-
What is the market cap of AMIX currently?
-
The market value of AMIX currently stands at $4.94M with its latest stock price at $9.0901